Behavioral Health Integration Experts

Which State Leads the US in Lowering Opioid Prescriptions?

2018-07-17T21:16:50-04:00By |Behavioral Health Integration, Care Coordination, Clinical Analysis, Clinical Operations Improvement, Strategic Planning|

Massachusetts currently leads the nation in decreasing opioids prescription, according to a Blue Cross Blue Shield report cited by The Boston Herald. Blue Cross Blue Shield's survey illustrated 51 percent fewer opioid prescriptions written in Massachusetts  in 2017 than 2013; specifically, Bay State physicians wrote 193 opioids prescriptions per 1,000 Blue Cross-insured members. The national average is 394 per 1,000 members. The study, published in Preventive Medicine, analyzed data from over 1,000 Americans. In a survey, the researchers queried respondents' attitudes on needle exchanges, (where people can dispose of used syringes and get sterile ones), safe injection sites (where people can use drugs under medical supervision) and broader opinions on addiction.

4 States With Big Drop in Opioid Prescriptions

2018-06-19T18:32:47-04:00By |Behavioral Health Integration, Care Coordination, Clinical Analysis, Clinical Operations Improvement, Strategic Planning|

Although needle exchanges and safe injection sites have numerous studies backing their effectiveness in fighting opioid addiction, a recent study revealed many Americans oppose both — a stigma that could harm the nation's response to the opioid epidemic, Vox reports. The study, published in Preventive Medicine, analyzed data from over 1,000 Americans. In a survey, the researchers queried respondents' attitudes on needle exchanges, (where people can dispose of used syringes and get sterile ones), safe injection sites (where people can use drugs under medical supervision) and broader opinions on addiction.

Social Stigma Concerning Opioid Use Hinders Fight

2018-06-12T19:30:06-04:00By |Behavioral Health Integration, Care Coordination, Clinical Analysis, Clinical Operations Improvement, Strategic Planning|

Although needle exchanges and safe injection sites have numerous studies backing their effectiveness in fighting opioid addiction, a recent study revealed many Americans oppose both — a stigma that could harm the nation's response to the opioid epidemic, Vox reports. The study, published in Preventive Medicine, analyzed data from over 1,000 Americans. In a survey, the researchers queried respondents' attitudes on needle exchanges, (where people can dispose of used syringes and get sterile ones), safe injection sites (where people can use drugs under medical supervision) and broader opinions on addiction.

Healthy Options: Tech Companies Reduce Chronic Pain

2018-05-30T00:23:15-04:00By |Behavioral Health Integration, Care Coordination, Clinical Analysis, Clinical Operations Improvement, Strategic Planning|

Hinge Health, a San Francisco startup that developed a 12-week remote monitoring program to reduce chronic knee pain and back pain, has published the results of a randomized control study to illustrate the effectiveness of its program for chronic knee pain. The program is intended to provide a noninvasive alternative to surgery to reduce chronic musculoskeletal pain.

Mayo Clinic Guidelines Cut Opioid Prescriptions

2018-05-08T18:55:00-04:00By |Behavioral Health Integration, Care Coordination, Clinical Analysis, Clinical Operations Improvement, Strategic Planning|

WEA Trust, a Wisconsin-based not-for-profit insurer, does that by protecting patients prescribed opioids for the first time. Its pharmacy utilization management program limits initial opioid prescriptions to a seven-day supply. WEA Trust also collaborates with providers to ensure opioid prescriptions are evidence-based and medically appropriate. In just five months, opiate prescriptions dropped 27 percent, with 91,000 fewer pills dispensed.

Opioid Epidemic Slows At Pharmacy Level With Health Plan Help

2018-02-27T23:30:28-04:00By |Behavioral Health Integration, Care Coordination, Clinical Analysis, Clinical Operations Improvement, Strategic Planning|

WEA Trust, a Wisconsin-based not-for-profit insurer, does that by protecting patients prescribed opioids for the first time. Its pharmacy utilization management program limits initial opioid prescriptions to a seven-day supply. WEA Trust also collaborates with providers to ensure opioid prescriptions are evidence-based and medically appropriate. In just five months, opiate prescriptions dropped 27 percent, with 91,000 fewer pills dispensed.

Benchmark Study On The Opioid Crisis

2018-02-13T23:18:25-04:00By |Behavioral Health Integration, Care Coordination, Clinical Analysis, Clinical Operations Improvement, Strategic Planning|

The first nationwide benchmark study measuring the health care industry’s progress in combating the opioid crisis was released. This important baseline analysis shows the positive steps clinicians and insurance plans have taken together – and identifies specific actions that can be taken to reduce addiction and abuse.

Behavioral Health Challenges, Changes For America

2017-09-14T15:44:42-04:00By |Behavioral Health Integration, Mental Health Parity, Trends|

Population trend data outlines the behavioral health challenges and changes occurring throughout the United States. For payers, understanding the movement of population segments help estimate coverage patterns and potential for claims submissions. National Survey on Drug Use and Health (NSDUH) released an annual survey of the population of the United States ages 12 years or older. The main First Findings Report contains a cross-section of NSDUH data on substance use and substance use disorders, mental health issues among adults and adolescents, and co-occurring disorders.

Autism Care Costs: Healthcare’s Perfect Storm

2017-08-01T20:13:16-04:00By |Behavioral Health Integration, Financial Analysis, Health Care Reform, Health Insurance, Uncategorized|

Autism care costs balance in the middle of many competing issues and agendas leaving payers, providers, and consumers trying to sort out the facts from fictions. The size of the funding pie “…over the next 10 years [is] about a half a million youth with autism spectrum disorder (ASD) will enter adulthood. The majority of the costs in the U.S. health care systems for ASD are directed at the adult population: $175 to $196 billion for adults compared to $61 to $66 billion for children.” writes Monica Oss, CEO, Open Minds.

Go to Top